New article on PREV_PKDL's contribution in the fight against leishmaniasis

The article titled "Expanding research capacity into neglected tropical diseases" by Prof Dr Paul Kaye was published on July 8th on Pharmaphorum a leading online destination for healthcare and pharmaceutical industry news, insight and debate.

The article examines the challenges of developing tools to fight neglected tropical diseases, in particular leishmaniasis , and how the work developed within the PREV_PKDL project is advancing the search for a safe and efficacious vaccine for post kala-azar dermal leishmaniasis (PKDL).

“Through the capacity-building this project provides, we hope its reach will extend to provide support for research into other tropical diseases”

Read the the full article here: https://pharmaphorum.com/r-d/views-analysis-r-d/expanding-research-capacity-into-neglected-tropical-diseases/

Leishmania mexicana parasites in the amastigote stage, SEM. Credit: University of Oxford, Richard Wheeler. Attribution 4.0 International (CC BY 4.0)

Join the European Vaccine Initiative Mailing list

This project is part of the EDCTP2 Programme supported by the European Union (RIA2016V-1640)

Follow European Vaccine Initiative

  • Twitter - White Circle
  • LinkedIn - White Circle

Privacy Policy  |  Imprint  |  Contact us  |  Back to top

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative